Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
about
Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS.Embryonic cerebrospinal fluid nanovesicles carry evolutionarily conserved molecules and promote neural stem cell amplificationExosome platform for diagnosis and monitoring of traumatic brain injuryIntegrated Magneto-Electrochemical Sensor for Exosome Analysis.Detection and isolation of circulating exosomes and microvesicles for cancer monitoring and diagnostics using micro-/nano-based devices.Hypoxic enhancement of exosome release by breast cancer cells.Age-Related Changes in Plasma Extracellular Vesicle Characteristics and Internalization by Leukocytes.The Methods of Choice for Extracellular Vesicles (EVs) Characterization.Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in ratsStandardization of sample collection, isolation and analysis methods in extracellular vesicle research.Comparative analysis of discrete exosome fractions obtained by differential centrifugation.Effect of storage on physical and functional properties of extracellular vesicles derived from neutrophilic granulocytesGalectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis.MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development.Glioblastoma extracellular vesicles: reservoirs of potential biomarkers.Human aqueous humor exosomes.Physical characterization and profiling of airway epithelial derived exosomes using light scattering.Interactions of tumour-derived micro(nano)vesicles with human gastric cancer cells.Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxelThe Novel Methods for Analysis of Exosomes Released from Endothelial Cells and Endothelial Progenitor Cells.The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids.Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis.Could Microparticles Be the Universal Quality Indicator for Platelet Viability and Function?Towards traceable size determination of extracellular vesicles.Integrative nanomedicine: treating cancer with nanoscale natural products.Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts.Exosomes as mediators of platinum resistance in ovarian cancer.Tumor-derived exosomes: A message delivery system for tumor progression.The cis-acting signals that target proteins to exosomes and microvesicles.Biomarkers for early detection of ovarian cancer.Emerging technologies in extracellular vesicle-based molecular diagnostics.Cell-derived extracellular vesicles as a platform to identify low-invasive disease biomarkers.Emerging techniques in the isolation and characterization of extracellular vesicles and their roles in cancer diagnostics and prognostics.The major histocompatibility complex class I immunopeptidome of extracellular vesicles.Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery.Characterization of exosomes derived from ovarian cancer cells and normal ovarian epithelial cells by nanoparticle tracking analysis.Elucidating diversity of exosomes: biophysical and molecular characterization methods.The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma.
P2860
Q24616100-F7DD203C-6DB9-4D70-B934-2C9EE3FC1589Q27309031-92AF40B2-A569-4A7A-BAA2-AACBB8838590Q27321794-B1A4E1C7-019B-4B06-8998-7E494AC34AECQ28246267-8F8AFEED-5456-40F4-B743-A850EB7FA145Q28272483-97302F72-B10D-41C8-B37D-F5521B15A347Q30365308-9F0270C2-C31A-40F7-816C-2D499EF8B3D3Q30527905-E2BEEA12-902A-4282-B1FF-D92C7EFEC892Q33683521-C4AC1102-FA23-4D5E-9BAA-99F78BC615F9Q33838541-0067F000-F7F4-4AF6-AAC0-02AA19A2901AQ34138381-68FD855F-D325-4AAF-9F43-7FBFA91151ADQ34369038-73F741A7-DC6D-4272-9107-7AF2AF5D9E7CQ34474459-98F51236-0EB8-4B08-A5DB-0D5E38BB13D6Q34767689-2E0BFF9D-9052-45FA-B0FB-4EB6DE6CA5FCQ35026202-A8A399B5-041E-4DAF-90A4-65FDAC035009Q35036059-55DDD624-AB98-49F6-8B3F-27B9120462F6Q35122209-18579C1D-9F12-4ABF-80D2-12A150C19BA3Q35155865-7EAE6168-DCC9-40C0-BF86-120E8D1EC4AEQ35590488-291DA58D-7A4F-4CD4-A014-14113C909076Q36337082-CB1B020C-C640-4ECA-B503-ECD4A16EC4D1Q36356460-A5A86EDE-145E-4428-A2CF-5B74F668F183Q36784843-855B9238-9B1A-459F-90B6-54FB3C3F430DQ37054618-18929B64-0DBE-4A74-81B1-DD3BDA12F939Q37141149-0E501568-0023-4E06-8B2F-207ADEDEB259Q37141158-431032A4-C174-482D-A03C-F2FE55F9AB7FQ37526973-283CFC70-E9EF-470E-AA18-A210AB378812Q37563988-281E212E-9F49-49BB-9BD7-B0B28A892828Q37578847-C63B1E4E-190C-4BBC-BCDE-5FBA508CEFD5Q37701607-B29778F4-FB03-4F33-A60C-5CE30CB0F4DDQ37707018-839950E4-06A2-453A-8754-6590E96EC7AFQ37716749-DAFC8D60-94E4-4D5E-B46F-0A3C7199FE85Q38077241-9791DD0E-23CD-431A-94EB-FF9624F4EAFEQ38087982-DA4A3FCB-F693-416F-8C1C-E2BB53FF69E9Q38191663-9ACB4AFD-F8FA-4DFE-8E04-0D80CB5B709CQ38463053-69128B39-B5A9-4217-9AB6-990F8A985C7DQ38624837-3B53ADD4-5162-45A8-B759-2D755941BE89Q38693646-D853555C-791D-4CF9-8B9D-2747EFB65BDBQ38773416-04C40616-D827-48DB-94FC-F67FFBB7CB9DQ38826007-F8382D4D-0FB3-459E-9926-2A479E2BEC99Q38917377-2CF8A369-C975-44FC-9A1E-A6E12EFE1AFFQ38975570-0CBC5B39-4A96-4F23-8591-CE5073673CE2
P2860
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
@ast
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
@en
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
@nl
type
label
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
@ast
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
@en
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
@nl
prefLabel
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
@ast
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
@en
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
@nl
P2093
P921
P356
P1476
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients
@en
P2093
Cicek Gercel-Taylor
Douglas D Taylor
Mehmet Kesimer
Richard H Tullis
P356
10.1016/J.AB.2012.06.004
P407
P50
P577
2012-06-09T00:00:00Z